PLRX
PLRX
NASDAQ · Pharmaceuticals

Pliant Therapeutics Inc

$0.81
-0.01 (-0.91%)
Analyst Consensus
Strong Sell
9
Analysts
Moderate
Coverage
Buy 0 0%
Hold 5 56%
Sell 4 44%
Price Target
Analyst Price Target +2,012.8% upside
Low Target $13.48
Average Target $17.08
High Target $25.30
Current Price $0.81
Current
$0.81
Target
$17.08
$13.48 $17.08 avg $25.30
Scenario Analysis
Bear Case
$13.48
1,567.5%
Low target
Base Case
$17.08
+2,012.8%
Avg target
Bull Case
$25.30
+3,029.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.82
-55.5% from high
52-Week Low
$0.83
+-2.6% from low
Target vs 52W High
$17.08
+841.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%